Edition:
United States

Nabriva Therapeutics PLC (NBRV.OQ)

NBRV.OQ on NASDAQ Stock Exchange Global Select Market

3.46USD
20 Jul 2018
Change (% chg)

$0.04 (+1.17%)
Prev Close
$3.42
Open
$3.42
Day's High
$3.55
Day's Low
$3.40
Volume
28,158
Avg. Vol
80,625
52-wk High
$14.09
52-wk Low
$3.31

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 7.55 -0.361
FY 2017 Dec '17 1.12 -0.584
Sep '17 1.47 -0.791
Jun '17 1.05 -0.537
Mar '17 1.68 -5.596
FY 2016 Dec '16
Sep '16 0.97 -0.658
Jun '16 1.78 -0.570
Mar '16 1.42 -6.421
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 7 2.03 6.70 0.60 1.70
Quarter Ending Dec-18 7 1.08 2.65 0.50 1.70
Year Ending Dec-18 8 10.87 16.30 7.40 5.37
Year Ending Dec-19 8 16.12 22.90 7.00 19.65
Earnings (per share)
Quarter Ending Sep-18 7 -0.47 -0.32 -0.65 -0.46
Quarter Ending Dec-18 7 -0.48 -0.35 -0.74 -0.47
Year Ending Dec-18 8 -1.82 -1.55 -2.36 -2.11
Year Ending Dec-19 8 -1.80 -1.23 -2.41 -1.59
LT Growth Rate (%) 2 28.05 97.20 -41.10 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 217.69 33.34
P/E High - Last 5 Yrs. -- 284.50 47.12
P/E Low - Last 5 Yrs. -- 96.76 24.95
Beta -- 0.76 0.81
Price to Sales (TTM) 12.44 256.17 8.11
Price to Book (MRQ) 1.57 21.19 4.23
Price to Tangible Book (MRQ) 1.58 27.03 6.21
Price to Cash Flow (TTM) -- 128.89 22.22
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.72
Dividend Yield - 5 Year Avg -- 0.21 1.46
Dividend 5 Year Growth Rate -- 2.25 -6.39
Payout Ratio(TTM) -- 84.35 47.39

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 350.00 33.43 4.76
Sales (TTM) vs TTM 1 Yr. Ago 66.03 147.14 12.32
Sales - 5 Yr. Growth Rate -- 30.77 7.68
EPS (MRQ) vs Qtr. 1 Yr. Ago 93.54 -79.61 48.99
EPS (TTM) vs TTM 1 Yr. Ago 90.81 -- --
EPS - 5 Yr. Growth Rate -- 46.75 7.97
Capital Spending - 5 Yr. Growth Rate -- 42.60 7.61

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.72 2.56
Current Ratio (MRQ) 8.65 6.63 3.63
LT Debt to Equity (MRQ) 0.46 24.46 13.08
Total Debt to Equity (MRQ) 0.46 28.66 17.18
Interest Coverage (TTM) -111.99 -154.53 35.06

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -49.14 55.90 55.23
Gross Margin - 5 Yr. Avg. -- 53.43 53.18
EBITD Margin (TTM) -633.87 -- --
EBITD - 5 Yr. Avg -- -182.15 15.61
Operating Margin (TTM) -638.24 -964.42 -0.70
Operating Margin - 5 Yr. Avg. -- -195.77 10.75
Pre-Tax Margin (TTM) -634.05 -858.38 1.18
Pre-Tax Margin - 5 Yr. Avg. -- -200.51 10.87
Net Profit Margin (TTM) -640.41 -849.10 -2.12
Net Profit Margin - 5 Yr. Avg. -- -198.30 7.23
Effective Tax Rate (TTM) -- 14.86 20.83
Effective Tax Rate - 5 Yr. Avg. -- 19.04 24.29

Efficiency

  Company industry sector
Revenue/Employee (TTM) 127,182 23,539,371 740,084,415
Net Income/Employee (TTM) -814,489 -1,115,845 86,307,671
Receivable Turnover (TTM) 1.61 17.88 5.95
Inventory Turnover (TTM) -- 2.85 3.69
Asset Turnover (TTM) 0.12 0.48 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -79.90 -2.23 10.36
Return on Assets - 5 Yr. Avg. -- 2.95 11.03
Return on Investment (TTM) -94.22 -3.65 13.18
Return on Investment - 5 Yr. Avg. -- 2.79 14.26
Return on Equity (TTM) -94.83 -5.62 15.09
Return on Equity - 5 Yr. Avg. -- -4.53 15.57
  1 Year 3 Year 5 Year
Sales % -17.94 -- --
EPS (TTM) % 90.35 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Nabriva Therapeutics PLC

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -9.42 -10.94 25 45
13 Week -33.84 -36.95 12 62
26 Week -47.50 -47.34 12 69
52 Week -67.02 -70.88 9 85
YTD -42.14 -44.79 15 86
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 74.43%
# of Holders: 62
Total Shares Held: 30,293,114
3 Mo. Net Change: 31,716
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 1
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.